Skip to main content
Skip to section navigation
Skip to footer
Home
Home
About Us
Programs
Anti-TNF
Synthetic CBD Analogs (SCAs)
a7nAChR Program
Pipeline
Leadership
Investors
Contact Us
Contact Us
Press Releases
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Year
All Years
2024
2023
2022
2021
2020
Oct 06, 2020 2:25pm EDT
180 Life Sciences Corp. Expands Intellectual Property Portfolio
Oct 05, 2020 1:00pm EDT
180 Life Science Corp. Announces New Board of Directors Appointments
Previous Page
arrow_back
Page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
Page
10
rss_feed
News RSS
Email Alerts
Contacts
RSS News Feed